Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation (Q45204007)

10 December 2017

title

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activation (English)

1 reference

10 December 2017

1 reference

Ulbrich K

1 reference

10 December 2017

Etrych T

1 reference

10 December 2017

Chytil P

1 reference

10 December 2017

Jelínková M

1 reference

10 December 2017

Ríhová B

1 reference

10 December 2017

publication date

1 January 2004

1 reference

Journal of Drug Targeting

10 December 2017

published in

1 reference

10 December 2017

1 reference

10 December 2017

1 reference

10 December 2017

page(s)

477-489

1 reference

Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

HPMA copolymers platinates containing dicarboxylato ligands. Preparation, characterisation and in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

Differences in the intracellular fate of free and polymer-bound doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

Water soluble polymers in tumor targeted delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

Cytoplasmic delivery and nuclear targeting of synthetic macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

Subcellular trafficking of HPMA copolymer-Tat conjugates in human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

Clinical Implications of N-(2-Hydroxypropyl)Methacrylamide Copolymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

Binding and cytotoxicity of HPMA copolymer conjugates to lymphocytes mediated by receptor-binding epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860400011869

10.1080/10611860400011869

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference